219 related articles for article (PubMed ID: 16492422)
1. Selective serotonin reuptake inhibitors in pediatric psychopharmacology: a review of the evidence.
Hammerness PG; Vivas FM; Geller DA
J Pediatr; 2006 Feb; 148(2):158-65. PubMed ID: 16492422
[No Abstract] [Full Text] [Related]
2. SSRI adverse events: how to monitor and manage.
Murphy TK; Segarra A; Storch EA; Goodman WK
Int Rev Psychiatry; 2008 Apr; 20(2):203-8. PubMed ID: 18386213
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitors for children and adolescents.
Kastelic EA; Labellarte MJ; Riddle MA
Curr Psychiatry Rep; 2000 Apr; 2(2):117-23. PubMed ID: 11122943
[TBL] [Abstract][Full Text] [Related]
4. Supportive psychotherapy, SSRIs, and MDD.
Hamilton J; Bridge J
J Am Acad Child Adolesc Psychiatry; 2006 Jan; 45(1):6-7. PubMed ID: 16327576
[No Abstract] [Full Text] [Related]
5. Should selective serotonin reuptake inhibitors be prescribed for children with major depressive and anxiety disorders?
Safer DJ
Pediatrics; 2006 Sep; 118(3):1248-51. PubMed ID: 16951019
[No Abstract] [Full Text] [Related]
6. Plasma fluoxetine concentrations and clinical improvement in an adolescent sample diagnosed with major depressive disorder, obsessive-compulsive disorder, or generalized anxiety disorder.
Blázquez A; Mas S; Plana MT; Gassó P; Méndez I; Torra M; Arnaiz JA; Lafuente A; Lázaro L
J Clin Psychopharmacol; 2014 Jun; 34(3):318-26. PubMed ID: 24743718
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitor use in the treatment of the pediatric non-obsessive-compulsive disorder anxiety disorders.
Seidel L; Walkup JT
J Child Adolesc Psychopharmacol; 2006; 16(1-2):171-9. PubMed ID: 16553537
[TBL] [Abstract][Full Text] [Related]
8. Carbamazepine for serotonin reuptake inhibitor nonresponder case of obsessive compulsive disorder.
Aggarwal A; Jain M; Garg A; Jiloha RC
Indian J Med Sci; 2009 Oct; 63(10):468-9. PubMed ID: 19901487
[No Abstract] [Full Text] [Related]
9. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
[TBL] [Abstract][Full Text] [Related]
10. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
Ammar G; Naja WJ; Pelissolo A
Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
[TBL] [Abstract][Full Text] [Related]
11. A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy.
De Berardis D; Serroni N; Campanella D; Olivieri L; Moschetta FS; Conti CM; Conti P; Di Giannantonio M
J Clin Psychopharmacol; 2012 Apr; 32(2):289-90. PubMed ID: 22388158
[No Abstract] [Full Text] [Related]
12. Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.
Benkert O; Wetzel H; Szegedi A
Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():3-14. PubMed ID: 8254151
[No Abstract] [Full Text] [Related]
13. Selective serotonin reuptake inhibitor-induced spermatorrhea in 2 patients.
Nakajima S; Uchida H; Suzuki T; Watanabe K; Kashima H
J Clin Psychiatry; 2009 Aug; 70(8):1192-3. PubMed ID: 19758534
[No Abstract] [Full Text] [Related]
14. Extended-release fluvoxamine (Luvox CR).
Med Lett Drugs Ther; 2008 Jun; 50(1289):50-1. PubMed ID: 18583947
[No Abstract] [Full Text] [Related]
15. Drugs to Treat Anxiety Disorders and Obsessive Compulsive Disorder (OCD).
J Psychosoc Nurs Ment Health Serv; 2024 May; 62(5):5-6. PubMed ID: 38709092
[No Abstract] [Full Text] [Related]
16. Obsessive compulsive disorder is not an anxiety disorder.
Montgomery SA
Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():57-62. PubMed ID: 8254154
[No Abstract] [Full Text] [Related]
17. Use of venlafaxine in other psychiatric disorders.
Ninan PT
Depress Anxiety; 2000; 12 Suppl 1():90-4. PubMed ID: 11098421
[TBL] [Abstract][Full Text] [Related]
18. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder.
Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA
J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069
[TBL] [Abstract][Full Text] [Related]
19. SSRIs: Prozac and company - part I.
Harv Ment Health Lett; 2000 Oct; 17(4):1-3. PubMed ID: 11015755
[No Abstract] [Full Text] [Related]
20. Pharmacologic treatment of children and adolescents with obsessive-compulsive disorder.
Scahill L; Lynch KA
J Child Adolesc Psychiatr Nurs; 1995; 8(4):36-40. PubMed ID: 8630647
[No Abstract] [Full Text] [Related]
[Next] [New Search]
